CLINICAL_TRIALS
trial_result
· 2020-02-17
Clinical Trial Update: Crohn's Allogeneic Transplant Study [Phase 2]
Summary
A Phase 2 allogeneic transplant study for Crohn's disease was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fred Hutchinson Cancer Center | Conditions: Crohn Disease | Phase 2 | Status: TERMINATED | Results posted: 2020-02-17